Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8618 |
High Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD2533 |
Approved |
0.8516 |
High Similarity |
NPD2532 |
Approved |
0.8516 |
High Similarity |
NPD2534 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8438 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8383 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8377 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8282 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8235 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8235 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8221 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8187 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8077 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8075 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD3748 |
Approved |
0.805 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7988 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7976 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7964 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7962 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD37 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7892 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7829 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7829 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7785 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7771 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD920 |
Approved |
0.7722 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7711 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7711 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.764 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5402 |
Approved |
0.761 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7572 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD2801 |
Approved |
0.755 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7548 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7547 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7515 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7486 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7456 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7418 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD4288 |
Approved |
0.741 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7405 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7378 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7325 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7322 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7306 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7472 |
Approved |
0.729 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7288 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7284 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7284 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD919 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD5691 |
Approved |
0.719 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1778 |
Approved |
0.717 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7159 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7115 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7115 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7107 |
Intermediate Similarity |
NPD411 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7104 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7098 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7091
|
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |